Wij zijn onze website aan het vernieuwen.

Ontdekt u nog een pagina die niet klopt of hebt u een goede suggestie, laat het ons dan weten via webmedia@umcutrecht.nl.

Deze website maakt gebruik van cookies

Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Lees meer over het cookiebeleid.

dr. S. (Stefan) Nierkens Associate Professor - medical

  • Laboratory for Translational Immunology (LTI)
  • Laboratory for Translational Immunology (LTI)

S. Nierkens

Contact

Research Programs

Biography

Dr. Stefan Nierkens (PhD) is Associate Professor and Medical Immunologist, accredited according to guidelines of the College of Medical Immunologists of the Dutch Society of Immunology, in the UMC Utrecht and Princess Máxima Center for Pediatric Oncology. Within the ISO15189-accredited laboratory his focus areas are Hemato-oncology, Immune monitoring, Cell and functional diagnostics, and Serology.

Dr. Nierkens is Associate Professor Pediatric Tumor Immunology and HCT and focusses on the development of innovative immunotherapy treatment strategies (based on dendritic cells and gene-engineered T cells) to improve the outcome of pediatric cancers (e.g. acute leukemia and neuroblastoma). Furthermore, his lab (12 fte) focuses on the combination of advanced immune monitoring and PK-PD modeling to provide predictable immune reconstitution after hematopoietic cell transplantation.

Dr. Nierkens is head of the Central Immune Monitoring Platform (8 fte) of the UMC Utrecht. He facilitates translational research in clinically well-defined (sub)cohorts of patients suffering from cancer, inflammatory and immune-mediated diseases.

Side Activities

  • None

Fellowship and Awards

  • KWF fellowship

    Kika

    ZonMW-TAS

    VillaJoep

    Ammodo

Research Output (178)

Quantification of T Cell Binding Polyclonal Rabbit Anti-thymocyte Globulin in Human Plasma with Liquid Chromatography Tandem-Mass Spectrometry

Amrani Mohsin El, Admiraal Rick, Willaert Lobke, Ebskamp-van Raaij Lysette J C, Lacna Amelia M, Hack C Erik, Huitema Alwin D R, Nierkens Stefan, van Maarseveen Erik M 1 mrt 2020, In: AAPS Journal. 22 8 p.

Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

Ariens Lieneke F. M., van der Schaft Jorien, Bakker Daphne S., Balak Deepak, Romeijn Margreet L. E., Kouwenhoven Tessa, Kamsteeg Marijke, Giovannone Barbara, Drylewicz Julia, van Amerongen Cynthia Catalina Aurora, Delemarre Evelien M., Knol Edward F., van Wijk Femke, Nierkens Stefan, Thijs Judith L., Schuttelaar Marie L. A., de Bruin-Weller Marjolein S. 1 jan 2020, In: Allergy. 75 , p. 116-126 11 p.

Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

Ariens Lieneke F. M., van der Schaft Jorien, Bakker Daphne S., Balak Deepak, Romeijn Margreet L. E., Kouwenhoven Tessa, Kamsteeg Marijke, Giovannone Barbara, Drylewicz Julia, van Amerongen Cynthia Catalina Aurora, Delemarre Evelien M., Knol Edward F., van Wijk Femke, Nierkens Stefan, Thijs Judith L., Schuttelaar Marie L. A., de Bruin-Weller Marjolein S. 1 jan 2020, In: Allergy. 75 , p. 116-126 11 p.

Phenotypic variability including Behçet's disease-like manifestations in DADA2 patients due to a homozygous c.973-2A>G splice site mutation.

van Well G.T.J., Kant Benjamin, Nisterlrooij A, Ekmekci S, Henriet Stefanie, Hoppenreijs E.P.A.H., van Deuren M., van Montfrans JM, Nierkens Stefan, Gul A, van Gijn Marielle 9 dec 2019, In: Clinical and Experimental Rheumatology. 37 , p. 142-146

Phenotypic variability including Behçet's disease-like manifestations in DADA2 patients due to a homozygous c.973-2A>G splice site mutation.

van Well G.T.J., Kant Benjamin, Nisterlrooij A, Ekmekci S, Henriet Stefanie, Hoppenreijs E.P.A.H., van Deuren M., van Montfrans JM, Nierkens Stefan, Gul A, van Gijn Marielle 9 dec 2019, In: Clinical and Experimental Rheumatology. 37 , p. 142-146

Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

Bakker Daphne S., Drylewicz Julia, Nierkens Stefan, Knol Edward F., Giovannone Barbara, Delemarre Eveline M., van der Schaft Jorien, Balak Deepak M.W., de Bruin-Weller Marjolein S., Thijs Judith L. dec 2019, In: Clinical and Experimental Allergy. 49 , p. 1641-1644 4 p.

Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

Bakker Daphne S., Drylewicz Julia, Nierkens Stefan, Knol Edward F., Giovannone Barbara, Delemarre Eveline M., van der Schaft Jorien, Balak Deepak M.W., de Bruin-Weller Marjolein S., Thijs Judith L. dec 2019, In: Clinical and Experimental Allergy. 49 , p. 1641-1644 4 p.

Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective

Beerepoot Shanice, Nierkens Stefan, Boelens Jaap-Jan, Lindemans Caroline, Bugiani Marianna, Wolf Nicole I. 4 nov 2019, In: Orphanet Journal of Rare Diseases. 14

Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective

Beerepoot Shanice, Nierkens Stefan, Boelens Jaap-Jan, Lindemans Caroline, Bugiani Marianna, Wolf Nicole I. 4 nov 2019, In: Orphanet Journal of Rare Diseases. 14

Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity

Thijs Judith L., Fiechter Renée, Giovannone Barbara, de Bruin-Weller Marjolein S., Knol Edward F., Bruijnzeel-Koomen Carla A.F.M., Drylewicz Julia, Nierkens Stefan, Hijnen Dirk Jan nov 2019, In: Allergy: European Journal of Allergy and Clinical Immunology. 74 , p. 2240-2243 4 p.

All Research Output (178)
To top